A beachhead in Warsaw
The launch of the orthopedics not-for-profit OrthoWorx is quite an accomplishment in Warsaw, where some of the world’s
biggest companies fight tooth-and-nail.
Life Science & Biotech
Articles
Lilly reorganization to cut 5,500 positions over 2 years
Eli Lilly and Co. will cut 5,500 jobs by the end of 2011 as it tries to cut $1 billion in expenses before it loses revenue
from its bestselling drug, Zyprexa. Lilly CEO John Lechleiter said he did not know how many of those cuts would occur in central
Indiana. But with
13,600 employees working in the Indianapolis area, he acknowledged the largest chunk of reductions likely would come here.
Medical device developer receives $1M in federal funding
Indianapolis-based FAST Diagnostics, a developer of a method to quickly measure kidney function, announced today that it has
received $1 million in federal funding.
BioCrossroads rolls out orthopedic initiative
With job growth surging in Warsaw’s orthopedic cluster, the life sciences development group BioCrossroads Inc. set out to…
Sweetener company Heartland looks for openings in crowded field
Heartland Sweeteners LLC is now a top maker of private-label alternatives to Splenda. The company also
markets its own products directly to consumers.
Exiting AgroSciences chief shook up strategy, culture
Jerome Peribere shifted Dow AgroScience’s focus toward what he calls “revolutionary solutions."
Cook predicts blockbuster with new stent
Bloomington-based Cook Medical has won European approval for a new artery-opening device for the legs that it predicts will
be a blockbuster.
INpact Medical Device Network matches start-ups with service providers
Industry groups in the life sciences, medical and information technology realms have helped lure companies to the region
and foster upstarts. Funding is almost always an issue, but it’s not the only barrier. Getting medical
devices to market often requires product design, development and marketing resources that aren’t
always apparent to upstarts.
Tenants trickling in to Purdue’s technology center
For a city feverishly growing its technology and life sciences sectors, it seemed a bit anticlimactic last January when
Purdue University dedicated its new technology center with only one tenant. But the lone tenant in the $12.8
million complex, FlamencoNets, a high-tech telecommunications firm, is about to get some company.
Abatement approval paves way for Covance jobs
The Hancock County Council this morning unanimously approved a tax-incentive agreement that should lead Covance Inc. to add
315 jobs at its Greenfield Laboratories.
Ron Henriksen has accumulated a lifetime of mergers and acquisitions
A light touch and an eye for detail have brought Ron Henriksen riches and adventure in a humble life of deal-making. And at
age 70, he has no plans to stop.
POWER BREAKFAST: Panel applauds progress, identifies challenges
A panel of five leaders of the state’s life sciences
industry took on a wide range of topics
July 24 at IBJ’s Power Breakfast
at the Westin Indianapolis.
Emerging life sciences companies grabbing more in government grants
More emerging life science companies have found life in the form of federal
Small Business Innovation Research grants.
Dow Chemical seems poised to keep AgroSciences
Midland, Mich.-based Dow Chemical Co. is still considering divesting Indianapolis subsidiary Dow AgroSciences LLC. But
chances that the chemical manufacturing giant will sell its local agricultural chemical and biotech unit appear to have decreased.
Lilly software spinoff Maaguzi sells for $11 million
Investors in a company built around clinical research software bought from Eli Lilly and Co. have found their exit, though
it’s far from the lucrative payoff they’d once imagined.
Is Indiana coming out of venture capital swoon?
Carmel-based Dormir LLC’s announcement July 29 of $12 million in venture financing was the second local life sciences
deal announced in July. It could suggest a turnaround from a woeful second-quarter performance, when Indiana life
sciences firms announced zero venture capital deals.
Lilly’s Effient launch just one of its many challenges
Eli Lilly and Co. has blasted past analysts’ earnings projections for two straight quarters. But if Lilly officials
take that as a sign they can breathe easier, they need only flip through a stack of Wall Street research reports on the company.
Dow Agro sale still possible, but less likely
Midland, Mich.-based Dow Chemical Co. is still considering divesting Indianapolis subsidiary Dow AgroSciences LLC. But chances
that the chemical manufacturing giant will sell its local agricultural chemical and biotech unit have decreased.
Dow AgroSciences names new CEO
Indianapolis-based Dow AgroSciences LLC will have a new CEO after its parent organization moves Jerome Peribere into a new
position, the company announced today. Antonio Galindez, 54, vice president of Dow AgroSciences’ crops business, will step
into the top job.
Dow AgroSciences names new CEO
Indianapolis-based Dow AgroSciences LLC will have a new CEO after its parent organization moves Jerome Peribere into a new
position, the company announced today.